SITC Archive Library

Back to Library

2017-2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Dallas Webinar 1 

09-03-2019 12:08

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the Dallas event is provided here. The purpose of this webinar series is to help attendees of the ACI program stay connected with regional experts, ask questions and receive guidance from program organizers.

Webinar Faculty:

  • Rolf Brekken, PhD – UT Southwestern Medical Center
  • Saad Khan, MD – UT Southwestern Medical Center

This webinar focused on irAE mechanism and management by dissecting a case study. Topics addressed in this webinar included:
  • Case study on mRCC treated with anti-PD-L1 Ab therapy
  • irAE management
  • Mechanism behind anti-PD-L1 and immune checkpoint adverse events
  • Biomarkers
  • Tumor mutation burden

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#Biomarkers#HeadandNeckCancers#RenalCellCarcinoma#RecordedWebinar
#AdvancesinCancerImmunotherapy(ACI)#SITC#AdverseEvents#Toxicities
#ImmuneCheckpointInhibitors#Ipilimumab#Nivolumab#CombinationTherapy
#AlliedHealth#Clinician#RegisteredNurse#Oncologist#Pharmacist
#PrimaryCarePhysician#2018

Statistics
0 Favorited
14 Views
1 Files
0 Shares
9 Downloads

​
Attachment(s)
mp4 file
2018 Advances in Cancer Immunotherapy™ Post Program Webin...   50.77 MB   1 version
Uploaded - 09-03-2019
Presenters: Rolf Brekken, PhD - UT Southwestern Medical Center, Saad Khan, MD - UT Southwestern Medical Center; Date: April 12, 2018; Length: 52:29
 
Download

Related Entries and Links

No Related Resource entered.